ERIBULIN MESYLATE

Product NDC
40033-364
Requested package NDC
40033-364-01
11-digit product format
400330364
Labeler code
40033
Product ID
40033-364_fcf8073d-d8a5-47be-8ecd-c8921b717a79
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
eribulin mesylate
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Kindos Pharmaceuticals Co., Ltd.
Application
ANDA218142
Marketing category
ANDA
Marketing start
2025-08-05
Marketing end
2026-12-01
Substance
ERIBULIN MESYLATE
Active strength
.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
NDC exclude flag
No
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218142-001ERIBULIN MESYLATEERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A218142-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-05d4dbc9d85df4…
2026-10-15 13:18:302026-09A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-05c2088c7a36db…
2026-09-14 22:38:342026-08A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-0584e616aacf4f…
2026-08-18 06:07:402026-07A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-05caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-05011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-0531067a03dcf5…
2025-08-23 18:47 UTC2025-08A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-056a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218142-001ERIBULIN MESYLATE1MG/2ML (0.5MG/ML)SOLUTION / INTRAVENOUSAP2025-08-05a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A218142-001AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09A218142-001AP1c2088c7a36db…
2026-09-14 22:38:342026-08A218142-001AP184e616aacf4f…
2026-08-18 06:07:402026-07A218142-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218142-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218142-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A218142-001AP16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218142-001AP1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
ERIBULIN MESYLATE

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ERIBULIN MESYLATE.5 mg/mL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f2cc096b-1048-9b7c-d909-76a5ea566cbfProduct name320251210

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
40033-364-01ERIBULIN MESYLATE2 mL in 1 VIAL, SINGLE-DOSEINJECTION24
40033-364-01ERIBULIN MESYLATE1 in 1 CARTONINJECTION14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ERIBULIN MESYLATEERIBULIN MESYLATEGLENMARK PHARMACEUTICALS INC., USA55f4017d-5ea8-4622-bf59-9b9c329097fd2025-10-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218142
application number: ANDA218142

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1045456eriBULin mesylate 1 MG in 2 ML InjectionPSN9bfd8ac7-57e2-4c9d-add8-26502cfb54a84
10454562 ML eribulin mesylate 0.5 MG/ML InjectionSCD9bfd8ac7-57e2-4c9d-add8-26502cfb54a84
1045456eribulin mesylate 1 MG per 2 ML InjectionSY9bfd8ac7-57e2-4c9d-add8-26502cfb54a84

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
40033-364-01400330364011 VIAL, SINGLE-DOSE in 1 CARTON (40033-364-01) / 2 mL in 1 VIAL, SINGLE-DOSE2025-08-052026-12-01NoNoHistorical